1. Home
  2. BOLD vs TPIC Comparison

BOLD vs TPIC Comparison

Compare BOLD & TPIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • TPIC
  • Stock Information
  • Founded
  • BOLD 2018
  • TPIC 1968
  • Country
  • BOLD United States
  • TPIC United States
  • Employees
  • BOLD N/A
  • TPIC N/A
  • Industry
  • BOLD
  • TPIC Industrial Machinery/Components
  • Sector
  • BOLD
  • TPIC Industrials
  • Exchange
  • BOLD Nasdaq
  • TPIC Nasdaq
  • Market Cap
  • BOLD 54.9M
  • TPIC 57.1M
  • IPO Year
  • BOLD 2024
  • TPIC 2016
  • Fundamental
  • Price
  • BOLD $2.65
  • TPIC $1.95
  • Analyst Decision
  • BOLD Buy
  • TPIC Hold
  • Analyst Count
  • BOLD 3
  • TPIC 5
  • Target Price
  • BOLD $22.50
  • TPIC $3.36
  • AVG Volume (30 Days)
  • BOLD 143.3K
  • TPIC 3.4M
  • Earning Date
  • BOLD 11-07-2024
  • TPIC 02-20-2025
  • Dividend Yield
  • BOLD N/A
  • TPIC N/A
  • EPS Growth
  • BOLD N/A
  • TPIC N/A
  • EPS
  • BOLD N/A
  • TPIC N/A
  • Revenue
  • BOLD N/A
  • TPIC $1,301,740,000.00
  • Revenue This Year
  • BOLD N/A
  • TPIC N/A
  • Revenue Next Year
  • BOLD N/A
  • TPIC $19.31
  • P/E Ratio
  • BOLD N/A
  • TPIC N/A
  • Revenue Growth
  • BOLD N/A
  • TPIC N/A
  • 52 Week Low
  • BOLD $2.33
  • TPIC $1.10
  • 52 Week High
  • BOLD $15.24
  • TPIC $5.75
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • TPIC 51.15
  • Support Level
  • BOLD N/A
  • TPIC $1.67
  • Resistance Level
  • BOLD N/A
  • TPIC $2.63
  • Average True Range (ATR)
  • BOLD 0.00
  • TPIC 0.34
  • MACD
  • BOLD 0.00
  • TPIC 0.13
  • Stochastic Oscillator
  • BOLD 0.00
  • TPIC 55.56

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About TPIC TPI Composites Inc.

TPI Composites Inc is engaged in manufacturing composite wind blades. The company operates in wind energy and transportation industries where it manufactures structures for a bus, rail, theme parks, and trucks. Geographically the segments are divided into the U.S, Asia, Mexico, EMEA and India where the Mexico segment derives a majority of revenue.

Share on Social Networks: